CARE™ Supplement CLL Case Study Series

Successful Initiation of Ven + R in Outpatient Setting

Issue 4

Hematology

26 Jan 2021

About Issue 4

Welcome to the 4th issue in the CARE™ CLL Case Study Series. This series provides context and guidance on how to navigate some of the challenges that specialists may face in routine practice. Issue 4 explores Successful Initiation of Venetoclax (Ven) + Rituximab (R) in Outpatient Setting. Profile and discussion follow.

Other Issues in the Series:

Issue 1 (Parts 1 & 2) explored identification and management of relapse after BTK inhibition. These publications are also available for download.
Issue 2 focuses on management of relapse after up-front chemoimmunotherapy. Profile and discussion content follows.
Issue 3 focuses on appropriate prevention of tumour lysis syndrome (TLS) with a modified titration schedule for starting patients on venetoclax. Profile and discussion content follows.